GA
AMGN icon

Geneva Advisors’s Amgen AMGN Stock Holding History

Geneva Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.16M Sell
6,730
-1,597
-19% -$260K 0.02% 335
2017
Q1 		$1.37M Buy
8,327
+308
+4% +$51.2K 0.02% 286
2016
Q4 		$1.17M Buy
8,019
+136
+2% +$20.5K 0.02% 300
2016
Q3 		$1.31M Buy
7,883
+249
+3% +$42.1K 0.02% 266
2016
Q2 		$1.16M Sell
7,634
-851
-10% -$132K 0.02% 283
2016
Q1 		$1.27M Sell
8,485
-2,637
-24% -$392K 0.03% 254
2015
Q4 		$1.8M Buy
11,122
+3,611
+48% +$568K 0.03% 210
2015
Q3 		$1.04M Buy
7,511
+608
+9% +$95.8K 0.02% 285
2015
Q2 		$1.06M Buy
6,903
+1,407
+26% +$225K 0.02% 301
2015
Q1 		$879K Buy
5,496
+115
+2% +$18.1K 0.02% 329
2014
Q4 		$857K Sell
5,381
-1,102
-17% -$172K 0.02% 320
2014
Q3 		$911K Sell
6,483
-134,593
-95% -$17.6M 0.02% 322
2014
Q2 		$16.7M Sell
141,076
-64,899
-32% -$7.51M 0.3% 87
2014
Q1 		$25.4M Buy
205,975
+203,730
+9,075% +$24.7M 0.47% 72
2013
Q4 		$256K Buy
2,245
+43
+2% +$4.89K ﹤0.01% 425
2013
Q3 		$246K Sell
2,202
-136
-6% -$14.7K 0.01% 425
2013
Q2 		$231K Buy
+2,338
New +$243K 0.01% 373

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geneva Advisors's AMGN Position: Q2 2017 in Review

Geneva Advisors reduced its Amgen (AMGN) stake by 19% in Q2 2017, selling an estimated $260K and leaving 6,730 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #335.

Geneva Advisors first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $25.4M in Q1 2014. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Geneva Advisors held 6,730 shares of Amgen worth $1.16M as of Q2 2017.
  • Geneva Advisors sold 1,597 Amgen shares in Q2 2017, an estimated $260K.
  • Amgen made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #335 holding.
  • Geneva Advisors first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Amgen position peaked at $25.4M in Q1 2014.
  • 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.